Costly Drug for Fatal Muscular Disease Wins F.D.A. Approval

Spinraza, a “life-changing” drug for spinal muscular atrophy, will cost as much as $750,000 for the first year of treatment and $375,000 annually after that.

from NYT > Health http://ift.tt/2iqWHDm
via health&fitness